Intelligent Bio Solutions (INBS) Depreciation & Amortization - Total (2023)
Intelligent Bio Solutions (INBS) recorded quarterly Depreciation & Amortization - Total of $17852.0 in Q2 2023, up 178.68% quarter-over-quarter from $6406.0 in Q1 2023.
Intelligent Bio Solutions (INBS) Depreciation & Amortization - Total (2023) Analysis & Trends
Intelligent Bio Solutions' Depreciation & Amortization - Total history runs 1 years deep, the most recent figure standing at $17852.0 for Q2 2023.
- In Q2 2023, Depreciation & Amortization - Total changed N/A year-over-year to $17852.0; the TTM figure through Mar 2024 stood at $17852.0 (up 178.68% YoY), while the FY2025 annual figure was $14955.0, down 1.01% from the prior year.
- Depreciation & Amortization - Total was $17852.0 for Q2 2023 at Intelligent Bio Solutions, up from $6406.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $17852.0 in Q2 2023 to a low of $6406.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 17,852.00 |
| Mar 31, 2023 | 6,406.00 |